237 related articles for article (PubMed ID: 27208382)
1. Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion Studies.
Kato K; Hasegawa Y; Iwata K; Ichikawa T; Yahara T; Tsuji S; Sugiura M; Yamaguchi J
Drug Metab Dispos; 2016 Aug; 44(8):1180-3. PubMed ID: 27208382
[TBL] [Abstract][Full Text] [Related]
2. Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.
Kawase A; Handa A; Iwaki M
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):519-526. PubMed ID: 27511381
[TBL] [Abstract][Full Text] [Related]
3. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.
Shingaki T; Takashima T; Ijuin R; Zhang X; Onoue T; Katayama Y; Okauchi T; Hayashinaka E; Cui Y; Wada Y; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
J Pharmacol Exp Ther; 2013 Oct; 347(1):193-202. PubMed ID: 23926287
[TBL] [Abstract][Full Text] [Related]
5. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
[TBL] [Abstract][Full Text] [Related]
6. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
Johnson DR; Habeebu SS; Klaassen CD
Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
[TBL] [Abstract][Full Text] [Related]
7. Tienilic acid enhances hyperbilirubinemia in Eisai hyperbilirubinuria rats through hepatic multidrug resistance-associated protein 3 and heme oxygenase-1 induction.
Nishiya T; Kataoka H; Mori K; Goto M; Sugawara T; Furuhama K
Toxicol Sci; 2006 Jun; 91(2):651-9. PubMed ID: 16543292
[TBL] [Abstract][Full Text] [Related]
8. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
[TBL] [Abstract][Full Text] [Related]
9. Biliary excretion of sulfated bile acids and organic anions in zone 1- and zone 3-injured rats.
Sasamoto T; Sano N; Takikawa H
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):26-31. PubMed ID: 16706808
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
[TBL] [Abstract][Full Text] [Related]
11. Function of multidrug resistance-associated protein 2 in acute hepatic failure rats.
Yokooji T; Murakami T; Yumoto R; Nagai J; Takano M
Eur J Pharmacol; 2006 Sep; 546(1-3):152-60. PubMed ID: 16899240
[TBL] [Abstract][Full Text] [Related]
12. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
Yamazaki M; Akiyama S; Ni'inuma K; Nishigaki R; Sugiyama Y
Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514
[TBL] [Abstract][Full Text] [Related]
13. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia.
Keppler D
Drug Metab Dispos; 2014 Apr; 42(4):561-5. PubMed ID: 24459177
[TBL] [Abstract][Full Text] [Related]
14. Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist).
Sandoval P; Chuang BC; Fallon JK; Smith PC; Chowdhury SK; Griffin RJ; Xia CQ; Iwasaki S; Chothe PP
AAPS J; 2022 Sep; 24(6):99. PubMed ID: 36123502
[TBL] [Abstract][Full Text] [Related]
15. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
Li X; Zhong K; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
[TBL] [Abstract][Full Text] [Related]
16. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
[TBL] [Abstract][Full Text] [Related]
17. The disposition of pravastatin in a rat model of streptozotocin-induced diabetes and organic anion transporting polypeptide 2 and multidrug resistance-associated protein 2 expression in the liver.
Hasegawa Y; Kishimoto S; Shibatani N; Inotsume N; Takeuchi Y; Fukushima S
Biol Pharm Bull; 2010; 33(1):153-6. PubMed ID: 20045956
[TBL] [Abstract][Full Text] [Related]
18. Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats.
Hotta K; Ueyama J; Tatsumi Y; Tsukiyama I; Sugiura Y; Saito H; Matsuura K; Hasegawa T
Anticancer Res; 2015 Sep; 35(9):4681-9. PubMed ID: 26254357
[TBL] [Abstract][Full Text] [Related]
19. Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.
Kato Y; Takahara S; Kato S; Kubo Y; Sai Y; Tamai I; Yabuuchi H; Tsuji A
Drug Metab Dispos; 2008 Jun; 36(6):1088-96. PubMed ID: 18339814
[TBL] [Abstract][Full Text] [Related]
20. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
Sheng J; Tian X; Xu G; Wu Z; Chen C; Wang L; Pan L; Huang C; Pan G
Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
